News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-10-07-2015
Volume11
Issue 10

SGS Attains Biosafety Level 2 Compliance at Fairfield, NJ Facility

SGS Life Science Services announced that its facility in Fairfield, NJ, has been upgraded to be Biosafety Level 2 (BSL-2) compliant, according to the Centers for Disease Control and Prevention (CDC) guidelines.

SGS Life Science Services, the bio/pharmaceutical analytical and bioanalytical contract solutions provider, announced that its facility in Fairfield, NJ, has been upgraded to be Biosafety Level 2 (BSL-2) compliant, according to the Centers for Disease Control and Prevention (CDC) guidelines. SGS has made significant investment in facilities and staff training to handle virulent organisms for the purposes of microbiological testing, chemical and raw-material testing, and stability testing of pharmaceutical materials.

With the enhanced containment capabilities, the facility is now able to support the development programs of biotech and pharmaceutical companies involved in vaccines against pathogens such as Poliovirus, Rotavirus, Influenza A, and Hepatitis A, B and C, also drugs against resistant bacterial strains, such as methicillin-resistant Staphylococcus aureus (MRSA), NDM-1 Escherichia coli, and Clostridium difficile.

SGS has seen an increase in demand for services from bio/pharmaceutical development companies, medical device manufacturers, and also environmental monitoring companies interested in such pathogens covered by the CDC guidelines, such as Legionella and Burkholderia cepacia. The range of products SGS can now work with at the Fairfield laboratory include both animal and human-derived samples such as blood (including serum, antibodies, and phagocytes) and tissue. 

This upgrade and investment comes three years after the Fairfield facility underwent a large scale expansion, doubling its footprint to 30,000 square feet. With 18 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides clinical trial management (Phase I to IV), and services encompassing data management and statistics, PK/PD modelling and simulation, pharmacovigilance and regulatory consultancy.

Source: SGS

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content